The Story Behind Manukahol Mentholated

In 2019, as COVID-19 emerged, respiratory therapist JT King developed Manukahol Mentholated—a patent-pending nebulized solution designed as a simple, effective home treatment for viral respiratory infections.

​

The Inspiration from Historical Therapy

Inspired by 1950s medical practices, where ethyl alcohol was nebulized to treat acute pulmonary edema by reducing foamy fluid in the lungs, JT chose 95% food-grade ethanol as the base. Known for killing viruses (as in hand sanitizers), it targets pathogens directly in the airways.

​

Adding Manuka Honey's Power

He enhanced the formula with premium Manuka honey, renowned for its superior antibacterial, antiviral, and anti-inflammatory properties. Its unique compound, methylglyoxal (MGO), disrupts protective biofilms, making viruses and bacteria more vulnerable. Honey has long soothed coughs, and nebulized forms reduce airway inflammation.

​

Completing the Formula with Menthol

To address persistent post-COVID coughs, JT added menthol, which provides cooling relief and reduces cough sensitivity.

​

Why It Targets Nasal and Respiratory Viruses

Manukahol Mentholated delivers these ingredients via nebulizer to the nasal passages and upper airways—where viruses like COVID, flu, and RSV first replicate and are detected by nasal swabs.

 

Real-World Experiences

Users report rapid results: JT recovered from COVID twice using it, others call it life-saving, and one grandfather saw his 3-year-old granddaughter’s RSV fever drop and energy return within an hour.

 

How to Verify It Works

For deeper lung symptoms, a three-session daily regimen helps. To verify effectiveness, users testing positive can schedule a retest after one dose—many report turning negative quickly.

​

Manukahol Mentholated blends proven science with natural ingredients for upper respiratory viral relief. Consult a healthcare professional before use.